Stonebridge Financial Planning Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300
Closed -$31K 263
2021
Q4
$31K Hold
300
0.02% 259
2021
Q3
$36K Hold
300
0.02% 247
2021
Q2
$38K Hold
300
0.02% 235
2021
Q1
$37K Hold
300
0.02% 234
2020
Q4
$35K Hold
300
0.02% 229
2020
Q3
$33K Hold
300
0.02% 223
2020
Q2
$28K Hold
300
0.02% 228
2020
Q1
$30K Hold
300
0.03% 206
2019
Q4
$34K Buy
+300
New +$32.9K 0.03% 193

Other funds holding MDT

Stonebridge Financial Planning Group's MDT Position: Q1 2022 in Review

Stonebridge Financial Planning Group sold out of Medtronic (MDT) in Q1 2022, closing a stake of 300 shares — an estimated $31K sold.

Stonebridge Financial Planning Group first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $38K in Q2 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Stonebridge Financial Planning Group reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 300 Medtronic shares in Q1 2022, an estimated $31K.
  • Stonebridge Financial Planning Group first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • Stonebridge Financial Planning Group's Medtronic position peaked at $38K in Q2 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2022, filed 10 May 2022.